(PDF) Reduction of Vertebral Fracture Risk in

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial

JAMA - Journal of the American Medical Association - United States

doi 10.1001/jama.282.7.637

Full Text

Abstract

Available in full text

Categories

Date

August 18, 1999

Authors

Publisher

American Medical Association (AMA)

Related search

Strontium Ranelate Reduces the Risk of Vertebral Fracture in Young Postmenopausal Women With Severe Osteoporosis

Annals of the Rheumatic Diseases

Molecular Biology

English

Assessment of Non-Vertebral Fracture Risk in Postmenopausal Women

Annals of the Rheumatic Diseases

Molecular Biology

English

Persistence and Adherence With Osteoporosis Medication and Re-Fracture in Women With Postmenopausal Osteoporosis in Taiwan

Value in Health

Occupational Health

English

Risk Factors of Adjacent Vertebral Collapse After Percutaneous Vertebroplasty for Osteoporotic Vertebral Fracture in Postmenopausal Women

BMC Musculoskeletal Disorders

Sports Medicine

English

Osteoporosis in Postmenopausal Women Living With HIV

Molecular Biology

English

Potassium Citrate Decreases Bone Resorption in Postmenopausal Women With Osteopenia: A Randomized, Double-Blind Clinical Trial

Endocrine Practice

English

The Prevalence and Structure of Major Risk Factors in Women With Postmenopausal Osteoporosis

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY

English

Pathogenetic Treatment With Strontium Ranelate in Women With Postmenopausal Osteoporosis

Modern Rheumatology Journal

English

Parathyroid Hormone Reduces Fractures in Postmenopausal Women With Osteoporosis

English